HAEMOGLOBIN-based oxygen-carrying (HBOC) solutions have been extensively developed and studied in the human medical field over the past three decades as a means of providing a readily available alternative to red blood cell (RBC) transfusion, due to increased concerns over disease transmission and limited supplies of human blood. Their use so far in human clinical medicine has been restricted by the lack of licensed products. Recently, an HBOC solution for the treatment of anaemia in dogs (Oxyglobin; Biopure) has been licensed in the UK. This article, based on the authors' experience of using the product to date, discusses the clinical applications, and limitations, of this new addition to the veterinary clinician's armoury.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.